MENU
+Compare
MAIA
Stock ticker: ASE
AS OF
Nov 19, 04:36 PM (EDT)
Price
$0.92
Change
-$0.09 (-8.91%)
Capitalization
37.4M

MAIA MAIA Biotechnology Forecast, Technical & Fundamental Analysis

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer... Show more

MAIA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for MAIA with price predictions
Nov 18, 2025

MAIA in -9.82% downward trend, falling for three consecutive days on November 13, 2025

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where MAIA declined for three days, in of 195 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day moving average for MAIA crossed bearishly below the 50-day moving average on October 17, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

The Aroon Indicator for MAIA entered a downward trend on November 17, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 13 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MAIA advanced for three days, in of 165 cases, the price rose further within the following month. The odds of a continued upward trend are .

MAIA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. MAIA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: MAIA's P/B Ratio (909.091) is very high in comparison to the industry average of (23.122). P/E Ratio (0.000) is within average values for comparable stocks, (61.014). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.073). Dividend Yield (0.000) settles around the average of (0.047) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (332.704).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MAIA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
MAIA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

MAIA is expected to report earnings to fall 51.85% to -12 cents per share on March 23

MAIA Biotechnology MAIA Stock Earnings Reports
Q4'25
Est.
$-0.13
Q3'25
Missed
by $0.08
Q2'25
Beat
by $0.01
Q1'25
Beat
by $0.02
Q4'24
Beat
by $0.03
The last earnings report on November 18 showed earnings per share of -27 cents, missing the estimate of -18 cents. With 150.38K shares outstanding, the current market capitalization sits at 37.40M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
444 West Lake Street
Phone
+1 312 416-8592
Employees
13
Web
https://www.maiabiotech.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EPSM2.701.28
+90.14%
Epsium Enterprise Limited
FEIM27.940.45
+1.66%
Frequency Electronics
JXN91.450.83
+0.92%
Jackson Financial
ISRG546.770.06
+0.01%
Intuitive Surgical
TNC69.25-0.63
-0.90%
Tennant Company

MAIA and Stocks

Correlation & Price change

A.I.dvisor tells us that MAIA and IPSC have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MAIA and IPSC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MAIA
1D Price
Change %
MAIA100%
+1.00%
IPSC - MAIA
32%
Poorly correlated
+1.99%
AVBP - MAIA
28%
Poorly correlated
-2.46%
JBIO - MAIA
27%
Poorly correlated
+0.52%
GOVX - MAIA
26%
Poorly correlated
+1.00%
RZLT - MAIA
26%
Poorly correlated
-0.49%
More